Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 23c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $28.61 +0.21%
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss): -65.15M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss): -65.15M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of $0.06, $0.23 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $93.97 million versus the consensus estimate of $60.48 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Reiterates Buy Rating on Volkswagen AG (VOW:GR) (VWAGY)
- JPMorgan Reiterates Overweight Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
- Rothschild Redburn Starts Equinix (EQIX) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
